Latest News

Those following along with Vitesse Energy, Inc. ( NYSE:VTS ) will no doubt be intrigued by the recent purchase of...

In late May 2026, Arcus Biosciences announced a clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate its HIF-2α inhibitor casdatifan in combination with BMS’s bispecific T‑cell engager pumitamig in the BMS-sponsored Phase 1/2 ROSETTA RCC‑208 study for advanced renal cell carcinoma. This collaboration adds new casdatifan-based arms to an existing BMS kidney cancer trial, potentially broadening Arcus’s clinical footprint in TKI‑free treatment approaches and...

We'd be surprised if Fiverr International Ltd. ( NYSE:FVRR ) shareholders haven't noticed that the Co-Founder, Micha...

In May 2026, BofA Securities upgraded Avient Corporation to Neutral from Underperform after the company reported past third-quarter fiscal 2026 results that exceeded revenue and EPS estimates, supported by a substantial backlog and book-to-bill ratios above 1 across regions. The combination of strong earnings and indications of an improving industry cycle, such as lengthening lead times in many areas, has shifted how investors may view Avient’s prospects. Next, we’ll examine how Avient’s...

Wondering whether Brown-Forman's share price still reflects what the business might be worth, or if the market has moved on faster than the fundamentals. The stock last closed at US$24.76, with returns that include a 4.5% decline over the past week, a 0.4% gain over the last month and declines of 5.3% year to date, 22.9% over 1 year, 59.2% over 3 years and 63.6% over 5 years. These longer term share price declines have kept Brown-Forman on investors' radars, as they reassess what a fair...

Why Voestalpine’s latest earnings matter for investors Voestalpine (WBAG:VOE) has drawn fresh attention after reporting full year results to March 31, 2026, with net income of €424.7 million on €15,063.1 million in sales and higher earnings per share. See our latest analysis for Voestalpine. The latest full year earnings seem to have reinforced interest in the stock, with a 1 month share price return of 11.16% and a year to date share price return of 21.93%. The 1 year total shareholder...

Globus Medical stock: context for recent moves Globus Medical (GMED) has been on many investors’ radars after recent trading, with the stock down about 14% over the past month and roughly 13% over the past 3 months despite solid profitability metrics. See our latest analysis for Globus Medical. While the share price has retreated recently, with the latest close at US$77.95 and short term momentum fading, the 1 year total shareholder return of 30.66% and 3 year total shareholder return of...

Recent share performance puts Cullen/Frost Bankers (CFR) in focus Cullen/Frost Bankers (CFR) has attracted investor attention after the stock fell about 3.6% over the past month and roughly 2.4% over the past 3 months, while it shows a year-to-date gain of 4.8%. See our latest analysis for Cullen/Frost Bankers. With the share price at $134.28, recent moves show short term momentum fading, with the 7 day and 30 day share price returns down 2.5% and 3.6%, while longer term total shareholder...

Copper Giant Resources earnings spark fresh look at the stock Copper Giant Resources (TSXV:CGNT) just posted first quarter 2026 results, reporting a net loss of CA$11.53 million and basic loss per share from continuing operations of CA$0.06, drawing renewed investor attention. See our latest analysis for Copper Giant Resources. The CA$0.795 share price has been volatile, with a 32.5% 1 month share price return and 60.61% year to date share price return. The 1 year total shareholder return is...

Berenberg recently initiated coverage on Vulcan Materials with a Hold rating, following the company’s Q1 2026 results that exceeded earnings and revenue expectations and its declaration of a quarterly cash dividend payable in June 2026. This combination of positive analyst attention and stronger-than-expected operating performance highlights Vulcan’s position in a structurally supported US aggregates market, where construction demand is projected by Berenberg to grow steadily. We’ll now...

Recent attention around Sensient Technologies (SXT) has been driven by the stock’s performance over the past 3 months and expectations that upcoming U.S. rules could favor its natural color ingredients business starting in 2027. See our latest analysis for Sensient Technologies. Beyond the immediate buzz around future U.S. rules, Sensient’s 90-day share price return of 20.98% and year to date share price return of 20.79% suggest building momentum. The 3-year total shareholder return of 53.63%...

Altria Group (MO) is back in focus after Q1 2026 revenue and earnings surpassed expectations, prompting upward earnings estimate revisions and fresh buy ratings, even as the stock lags the broader market. See our latest analysis for Altria Group. Altria’s share price has eased over the past month, with a 30 day share price return of down 4.24%. However, momentum over a longer horizon remains positive given the 22.67% year to date share price return and very strong multi year total shareholder...

Cognex's conference appearance and sharp share price move Cognex (CGNX) heads into its May 28 presentation at the Bernstein 42nd Annual Strategic Decisions Conference following a sharp share price rally, even as questions remain around revenue growth, earnings trends, and returns on invested capital. See our latest analysis for Cognex. At a share price of US$66.06, Cognex has delivered a strong 30 day share price return of 17.34% and a 1 year total shareholder return of 123.06%. This suggests...

Moderna (MRNA) stock is back in focus after five year follow up data showed its personalized mRNA cancer vaccine intismeran autogene, combined with Keytruda, significantly cut melanoma recurrence and death versus Keytruda alone. See our latest analysis for Moderna. The positive melanoma data helped drive a 1 day share price return of 7.49% to US$49.06. The year to date share price return of 58.98% sits against a 3 year total shareholder return that is down 60.94%, showing strong recent...

Recent share performance and what it may suggest First Quantum Minerals (TSX:FM) has caught investor attention after recent share price moves, with the stock up 14.1% over the past week and 45.9% over the past month, alongside a 115.4% total return over the past year. See our latest analysis for First Quantum Minerals. The recent 45.9% 1 month share price return and 115.4% 1 year total shareholder return suggest that momentum has been building, even after a small 1 day pullback, with the...

Leadership shake up and why it matters for Lincoln National stock Lincoln National (LNC) has reshaped its senior leadership, elevating three long-serving executives and splitting oversight of its Life Insurance and Annuities businesses, a move that could influence how investors think about the stock’s risk and earnings profile. See our latest analysis for Lincoln National. At a share price of US$33.53, Lincoln National has seen the share price fall 9.18% over the past 30 days and 25.51% year...

Dividend proposal puts Kurita Water Industries (TSE:6370) in focus Kurita Water Industries (TSE:6370) is back on investors’ radar after its board proposed a dividend of ¥56.00 per share for the fiscal year ended March 31, 2026, compared with ¥46.00 previously. See our latest analysis for Kurita Water Industries. The proposed higher dividend comes as Kurita Water Industries’ share price has gained momentum, with a 10.17% 1 month share price return and a 35.32% year to date share price return,...

Meiji Holdings (TSE:2269) has drawn investor attention after its board approved a year-end dividend of ¥52.50 per share for the fiscal year ended March 31, 2026, compared with ¥50.00 a year earlier. See our latest analysis for Meiji Holdings. At a share price of ¥3,656.0, Meiji Holdings has seen the share price fall over the past week and quarter, yet the year to date share price return is positive and the 1 year total shareholder return of 17.39% points to steadier long term momentum. If...

Why ADT (ADT) Is Drawing Fresh Attention Now ADT (ADT) is back on investors’ radar after recent trading pressure, with the stock down 2% on the day and roughly 6% over the past month. This is prompting closer scrutiny of its security and smart home business. See our latest analysis for ADT. With the share price at US$6.66 and the 1-year share price return down 16.85%, recent weakness follows a softer year for shareholders, although the 3-year total shareholder return of 15.52% shows a...

In recent updates prior to today, Neogen reported solid core growth in its Food Safety segment while supplier issues continued to weigh on its Animal Safety business, and management outlined progress on key operational initiatives. A particularly important development is Neogen’s plan to complete the transition of Petrifilm manufacturing by November 2026, which management believes should enhance margins and strengthen control over production. Next, we’ll examine how Neogen’s clearer...

In recent days, UBS resumed coverage on Blackstone Mortgage Trust Inc., assigning a Buy rating and highlighting its 15-year dividend record, while the company completed a US$450 million private offering of senior secured notes due 2031 to refinance existing secured debt and support general corporate purposes. Together, the renewed analyst attention and fresh long-term funding underline how Blackstone Mortgage Trust is emphasizing balance sheet flexibility while continuing to position itself...

Automatic Data Processing (ADP) is back in focus after its May National Employment Report showed private employers adding 122,000 jobs, topping forecasts and suggesting a steadier US labor market backdrop. See our latest analysis for Automatic Data Processing. At a share price of US$227.75, ADP has gained 7.8% on a 1 month share price return and 4.6% over the past week, although the share price is still down 9.9% year to date and the 1 year total shareholder return has declined 28.4%,...

Morningstar recently reported a 37% increase in operating income, expanded margins, and a 10% reduction in its share count while continuing to invest in platforms such as Morningstar Direct, PitchBook, and its growing credit ratings business. This combination of stronger profitability, meaningful buybacks, and ongoing investment in a gaining-market-share credit ratings arm points to a business reshaping its earnings profile while reinvesting for future growth. Next, we’ll examine how...

SBI Shinsei Bank campaign: why this new offer matters for the stock SBI Shinsei Bank (TSE:8303) has launched a campaign that offers ¥3,000 to customers who open an SBIハイパー預金 deposit account and buy eligible mutual funds through SBI Securities under Japan’s new NISA system. See our latest analysis for SBI Shinsei Bank. At a share price of ¥1,420.0, SBI Shinsei Bank has seen the 1-day share price return of 2.01% and 7-day share price return of 4.45% come after a 30-day share price decline of...